Novo Nordisk Q3 profit surpasses USD 1.8bn

The Danish pharmaceutical giant has revealed net profits of DKK 12bn (USD 1.8bn) for the third quarter of 2021, and DKK 36.8bn (USD 5.7bn) for the first nine months of the year.

Photo: Novo Nordisk / PR

Novo Nordisk has generated a DKK 12bn (USD 1.8bn) profit in the third quarter of 2021, significantly more than for the same period last year, where the bottom line was DKK 10.3bn (USD 1.6bn), according to its report released on Wednesday morning.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs